6ZEA LONG E L,WEINSTEIN P R,CARLSON S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20 (1):84-86.
7BEDERSON J B,PITTS L H,DAVIS R L,et al.Rat middle cerebralartery occlusion:evaluation of the model and development of aneuro logic exam ination[J].Stroke,1986,17(3):472-476.
8KUGE Y,MINEMATSU K,YAMAGACHI T,et al.Nylon monofilament for intraluminal middle cerebral artery occlusion in rats[J].Stroke,1995,26 (9):1655-1657.
9HuangYC, Chen CH, Chen SC. A natural compound (Ginsenoside Re) isolated from panax ginseng as a novel angiogenic agent for tissue regeneration [J]. Pharm Res, 2005, 22 (4): 636-646.
10Sun BS, Gu LJ, Fang ZM, et al. Simultaneous quantification of 19 ginsenosides in black ginseng developed from Panax ginseng by HPLC-ELSD [J]. Pharma Biomed Analy, 2009, 50 (1): 15-22.
1HINES I N,WHEELER M D.Recent advances in alcoholic liver disease Ill.Role of the innateimmune response in alcoholic hepatitis[J].Am J Physiol Gastrointest Liver Physiol,2004,287(2):310-314.
2KSONTINI R,COLAGIOVANNI D,SEQHS M D,et al.Disparate roles for TNF-αand Fas ligand in concanavalin A-induced hepatitis[J].J Immuno,1998,160(8):4082-4089.
3NEWTON R,HOLDEN N S.Separating transrepression and transactivation:a distressing divorce for the glucocorticoid receptor?[J].Mol Pharmaco,2007,72(4):799-809.
